An Observational Study of Respiratory Syncytial Virus (RSV) Hospitalizations in Preterm Infants
NCT02273882 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 497
Last updated 2017-05-23
Summary
Purpose of this study is to evaluate clinical, humanistic and health economic burden of Respiratory Syncytial Virus (RSV) in infants born 29 to 35 Weeks Gestational Age (wGA) hospitalized for RSV at up to 12 months of age.
Conditions
- Respiratory Syncytial Virus Hospitalizations
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Christopher Ambrose, MD · AstraZeneca
-
Veena Kumar, MD, MPH · AstraZeneca
Eligibility
- Max Age
- 12 Months
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2014-11-17
- Primary Completion
- 2016-08-19
- Completion
- 2016-08-19
Countries
- United States
Study Locations
More Related Trials
-
Assess the Correlation With Severe Respiratory Syncytial Virus Disease in the First 6 Months in Children With Congenital Heart Disease and Maternal Ac-AntiVSR Titers During Pregnancy
NCT04734782 ·Status: UNKNOWN
-
Transplacental Transmission of RSV (TTRSV)
NCT05443607 ·Status: ACTIVE_NOT_RECRUITING
-
Predictors of Respiratory Syncytial Virus (RSV) Hospitalizations in Infants
NCT04144816 ·Status: UNKNOWN
-
Prevention Strategy for Respiratory Syncytial Virus (RSV) Infections in Infants in France
NCT06881953 ·Status: RECRUITING
-
Respiratory Syncytial Virus (RSV) and Vaccination in Pregnancy
NCT03096574 ·Status: UNKNOWN
-
Severity of RSV Infections in Twins
NCT05070975 ·Status: COMPLETED
-
Disease Burden of RSV
NCT05506670 ·Status: COMPLETED ·Phase: NA
-
RSV Vaccine Pregnancy Registry
NCT06521944 ·Status: RECRUITING
-
Immune Response to Respiratory Syncytial Virus (RSV) in Health Care Workers
NCT01563692 ·Status: COMPLETED
-
Respiratory Syncytial Virus (RSV) Burden in Older Adults in Primary Care in The Netherlands
NCT06318936 ·Status: RECRUITING
-
Early-Onset Sepsis Surveillance Study
NCT00874367 ·Status: COMPLETED
-
RSV Antibiotic Drivers And Resource-use
NCT06977971 ·Status: COMPLETED
-
TGV:Use of the Quick Diagnostic Test of the Influenza and the Infection With RSV by the Paediatric Emergency Unit
NCT00263900 ·Status: COMPLETED ·Phase: NA
-
Respiratory Syncytial Virus Infection May be More Dangerous in Neonate
NCT04531735 ·Status: UNKNOWN
-
Infection With Respiratory Syncytial Virus in Infants
NCT04925310 ·Status: UNKNOWN
-
Procalcitonin for Predicting Serious Bacterial Infection in Infants Less Than 3 Months
NCT00800488 ·Status: COMPLETED
-
Impact of the Covid-19 on Respiratory Syncytial Virus (RSV) Epidemic
NCT04944160 ·Status: COMPLETED
-
FluLaval® Quadrivalent Pregnancy Registry
NCT02000466 ·Status: WITHDRAWN
-
Promotion of RSV Immunization Through Multiple Efforts
NCT06640868 ·Status: COMPLETED ·Phase: PHASE3
-
Observational Research in Childhood Infectious Diseases Study
NCT01304914 ·Status: COMPLETED
-
"COhort Study on A/H1N1 FLU During PREGnancy"
NCT01192737 ·Status: COMPLETED
-
Host RNA Profiles to Detect Infections in Young Infants
NCT04823026 ·Status: COMPLETED
-
Increasing Influenza and Tdap Vaccination of Pregnant Women
NCT04444518 ·Status: COMPLETED ·Phase: NA
-
Impact of the Covid-19 on RSV
NCT05348616 ·Status: UNKNOWN
-
Evaluation of the Evolution of Pregnancies in the First Trimester Following MAR Management During a COVD-19 Pandemic Period
NCT04415359 ·Status: COMPLETED